Qiang Xue

854 total citations
43 papers, 646 citations indexed

About

Qiang Xue is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Qiang Xue has authored 43 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Qiang Xue's work include Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers) and Cancer-related molecular mechanisms research (5 papers). Qiang Xue is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers) and Cancer-related molecular mechanisms research (5 papers). Qiang Xue collaborates with scholars based in China, United States and Hong Kong. Qiang Xue's co-authors include Yong Xia, Fuyan Xu, Luoting Yu, Xiaoyu Xu, Yang Liu, Xiaogang Xu, Tinghong Ye, Wentao Lin, Zhanzhan Feng and Ranran Wang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Nanoscale.

In The Last Decade

Qiang Xue

39 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Xue China 17 331 111 102 78 73 43 646
Ava Safaroghli‐Azar Iran 20 578 1.7× 82 0.7× 97 1.0× 147 1.9× 48 0.7× 45 969
Qiuhong Duan China 17 426 1.3× 72 0.6× 143 1.4× 78 1.0× 29 0.4× 46 782
Ning An China 17 352 1.1× 81 0.7× 136 1.3× 111 1.4× 43 0.6× 66 761
Yi Fu China 17 329 1.0× 85 0.8× 155 1.5× 69 0.9× 14 0.2× 44 898
Bowen Dong China 11 270 0.8× 42 0.4× 86 0.8× 101 1.3× 137 1.9× 25 578
Hsiao‐Mei Kuo Taiwan 20 456 1.4× 47 0.4× 147 1.4× 88 1.1× 16 0.2× 43 855
Inan Olmez United States 11 249 0.8× 161 1.5× 81 0.8× 172 2.2× 29 0.4× 14 696
Li Cai China 17 284 0.9× 62 0.6× 79 0.8× 76 1.0× 15 0.2× 51 684
Saeed Rezapoor Iran 18 345 1.0× 188 1.7× 81 0.8× 131 1.7× 39 0.5× 22 998
Qiuyan Wu China 17 310 0.9× 130 1.2× 128 1.3× 96 1.2× 11 0.2× 42 953

Countries citing papers authored by Qiang Xue

Since Specialization
Citations

This map shows the geographic impact of Qiang Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Xue more than expected).

Fields of papers citing papers by Qiang Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Xue. The network helps show where Qiang Xue may publish in the future.

Co-authorship network of co-authors of Qiang Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Xue. A scholar is included among the top collaborators of Qiang Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Xue. Qiang Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yang�, Xiaodi Yan, Jiajia Liu, et al.. (2024). Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation ofFOXO1. Current Pharmaceutical Design. 30(6). 440–447. 3 indexed citations
5.
Luo, T., Sen L, Xinquan Wang, et al.. (2024). Establishment of a scoring model for predicting clinical outcomes in patients with unilateral primary aldosteronism after superselective adrenal artery embolization. Irish Journal of Medical Science (1971 -). 193(5). 2269–2279. 2 indexed citations
6.
Wang, Xinquan, Sen Liu, Jixin Hou, et al.. (2023). A modified single-catheter approach for improving adrenal venous sampling in patients with primary aldosteronism. The Journal of Vascular Access. 26(1). 63–71. 2 indexed citations
7.
Xue, Qiang, Chen Wang, Zhiyong Cui, et al.. (2022). Cancer incidence and spectrum among Uygurs in Hotan District in China. Cancer Epidemiology. 80. 102217–102217.
8.
Wang, Hongjin, Xiaogang Xu, Xiaogang Xu, et al.. (2020). Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF. Phytomedicine. 78. 153300–153300. 50 indexed citations
9.
Xia, Yong, Fuyan Xu, Meiping Xiong, et al.. (2020). Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharmacological Research. 163. 105295–105295. 61 indexed citations
10.
Liu, Yong, Bin Ke, Bin Li, et al.. (2020). <p>A Preliminary Study on the Establishment of the PDTX Model</p>. Cancer Management and Research. Volume 12. 1969–1979. 1 indexed citations
11.
Wang, Feiran, et al.. (2020). Identifying the hub gene in gastric cancer by bioinformatics analysis and in vitro experiments. Cell Cycle. 19(11). 1326–1337. 20 indexed citations
12.
Tang, Qing, Hui Ke, Chao Wu, et al.. (2019). Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways. Journal of Ethnopharmacology. 239. 111925–111925. 19 indexed citations
13.
Xue, Qiang, Zhihao Liu, Zhanzhan Feng, et al.. (2019). Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis. Biomedicine & Pharmacotherapy. 121. 109598–109598. 23 indexed citations
14.
Xu, Fuyan, Yong Xia, Zhanzhan Feng, et al.. (2019). Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases.. PubMed. 9(3). 459–478. 41 indexed citations
15.
Wu, Chao, Hui Ke, Qiang Xue, et al.. (2019). You-Gui-Yin improved the reproductive dysfunction of male rats with chronic kidney disease via regulating the HIF1α-STAT5 pathway. Journal of Ethnopharmacology. 246. 112240–112240. 8 indexed citations
16.
Xue, Qiang, et al.. (2018). CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway. Neoplasma. 65(6). 888–897. 22 indexed citations
17.
Hou, Min, Qing Tang, Qiang Xue, et al.. (2016). Pharmacodynamic action and mechanism of Du Liang soft capsule, a traditional Chinese medicine capsule, on treating nitroglycerin-induced migraine. Journal of Ethnopharmacology. 195. 231–237. 30 indexed citations
18.
Xue, Qiang, Yang Liu, Ran He, et al.. (2016). Lyophilized Powder of Catalpol and Puerarin Protects Neurovascular Unit from Stroke. International Journal of Biological Sciences. 12(4). 367–380. 31 indexed citations
19.
Liu, Yang, Qiang Xue, Li Xu, et al.. (2014). Amelioration of Stroke-Induced Neurological Deficiency by Lyophilized Powder of Catapol and Puerarin. International Journal of Biological Sciences. 10(4). 448–456. 23 indexed citations
20.
Zhao, Jing, et al.. (2011). [Prognosis of patients with recurrence after curative resection of advanced gastric cancer].. PubMed. 14(2). 107–10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026